TI
SCPH

Trexquant Investment’s scPharmaceuticals SCPH Stock Holding History

Trexquant Investment’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,995
Closed -$60.9K – 1823
2024
Q2 		$60.9K Buy
+13,995
New +$61.5K ﹤0.01% 1480
2023
Q1 		– Sell
-14,964
Closed -$107K – 1731
2022
Q4 		$107K Buy
+14,964
New +$91.4K ﹤0.01% 1314
2020
Q4 		– Sell
-11,087
Closed -$83K – 1438
2020
Q3 		$83K Sell
11,087
-14,886
-57% -$116K 0.01% 1145
2020
Q2 		$191K Buy
25,973
+9,293
+56% +$81.6K 0.01% 1057
2020
Q1 		$123K Buy
+16,680
New +$121K 0.01% 1030

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Trexquant Investment's SCPH Position: Q3 2024 in Review

Trexquant Investment sold out of scPharmaceuticals (SCPH) in Q3 2024, closing a stake of 13,995 shares — an estimated $60.9K sold.

Trexquant Investment first reported a position in SCPH in Q1 2020 and held it in 5 quarters. The position peaked at $191K in Q2 2020. 95 funds tracked by Wall St. Rank hold SCPH as of Q3 2024.

  • Trexquant Investment reported no remaining scPharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 13,995 scPharmaceuticals shares in Q3 2024, an estimated $60.9K.
  • Trexquant Investment first reported a position in scPharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Trexquant Investment's scPharmaceuticals position peaked at $191K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.